Cardiac allograft vasculopathy prevention
Template:Cardiac Allograft Vasculopathy Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2] Raviteja Guddeti, M.B.B.S. [3]
Overview
Prevention
As the pathogenesis of CAV consists of both immunological and non-immunological insults, preventative strategies should consist of control of risk factors for CAV and optimal immunosuppressive therapy.
Optimization of Immunosuppressive Therapy
Options for immunosuppressive therapy for prevention of CAV includes:
- Calcineurin inhibitors, such as
- Rapamycin derivatives, such as
- Corticosteroids
- Azathioprine
- Mycophenolate mofetil